Xeroderma pigmentosum-variant patients from America, Europe, and Asia.

Xeroderma pigmentosum-variant (XP-V) patients have sun sensitivity and increased skin cancer risk. Their cells have normal nucleotide excision repair, but have defects in the POLH gene encoding an error-prone polymerase, DNA polymerase eta (pol eta). To survey the molecular basis of XP-V worldwide, we measured pol eta protein in skin fibroblasts from putative XP-V patients (aged 8-66 years) from 10 families in North America, Turkey, Israel, Germany, and Korea. Pol eta was undetectable in cells from patients in eight families, whereas two showed faint bands. DNA sequencing identified 10 different POLH mutations. There were two splicing, one nonsense, five frameshift (3 deletion and 2 insertion), and two missense mutations. Nine of these mutations involved the catalytic domain. Although affected siblings had similar clinical features, the relation between the clinical features and the mutations was not clear. POLH mRNA levels were normal or reduced by 50% in three cell strains with undetectable levels of pol eta protein, indicating that nonsense-mediated message decay was limited. We found a wide spectrum of mutations in the POLH gene among XP-V patients in different countries, suggesting that many of these mutations arose independently.

[1]  Ayumi Yamada,et al.  Complementation of defective translesion synthesis and UV light sensitivity in xeroderma pigmentosum variant cells by human and mouse DNA polymerase , 2000, Nucleic Acids Res..

[2]  S. Li,et al.  Structure of the ubiquitin‐binding zinc finger domain of human DNA Y‐polymerase η , 2007, EMBO reports.

[3]  A. Sarasin,et al.  Molecular analysis of mutations in DNA polymerase η in xeroderma pigmentosum-variant patients , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K. Kraemer,et al.  Xeroderma pigmentosum – bridging a gap between clinic and laboratory , 2001, Photodermatology, photoimmunology & photomedicine.

[5]  M. Yamaizumi,et al.  Reinvestigation of the classification of five cell strains of xeroderma pigmentosum group E with reclassification of three of them. , 2000, The Journal of investigative dermatology.

[6]  P. Gearhart,et al.  DNA polymerase η is an A-T mutator in somatic hypermutation of immunoglobulin variable genes , 2001, Nature Immunology.

[7]  K. Kraemer,et al.  Xeroderma Pigmentosum: An Inherited Disease with Sun Sensitivity, Multiple Cutaneous Neoplasms, and Abnormal DNA Repair , 1974 .

[8]  J. Cleaver,et al.  Xeroderma pigmentosum: variants with normal DNA repair and normal sensitivity to ultraviolet light. , 1972, The Journal of investigative dermatology.

[9]  M. Yamaizumi,et al.  Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation. , 2000, The Journal of investigative dermatology.

[10]  E. Friedberg,et al.  DNA Repair and Mutagenesis , 2006 .

[11]  R. Schiffmann,et al.  Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: A complex genotype–phenotype relationship , 2007, Neuroscience.

[12]  Sikandar G. Khan,et al.  Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. , 2006, Carcinogenesis.

[13]  E. G. Frank,et al.  Sequence context-dependent replication of DNA templates containing UV-induced lesions by human DNA polymerase iota. , 2003, DNA repair.

[14]  L. Maquat,et al.  Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges. , 2006, Trends in molecular medicine.

[15]  Sikandar G. Khan,et al.  A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor. , 2001, The Journal of investigative dermatology.

[16]  R. Woodgate,et al.  Structure-based interpretation of missense mutations in Y-family DNA polymerases and their implications for polymerase function and lesion bypass. , 2002, DNA repair.

[17]  R. Woodgate,et al.  What a difference a decade makes: Insights into translesion DNA synthesis , 2007, Proceedings of the National Academy of Sciences.

[18]  K. Kraemer,et al.  Xeroderma Pigmentosum: Cutaneous, Ocular, and Neurologic Abnormalities in 830 Published Cases , 1987 .

[19]  J. Vockley,et al.  Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene. , 2000, American journal of human genetics.

[20]  R. Woodgate,et al.  Replication of a cis–syn thymine dimer at atomic resolution , 2003, Nature.

[21]  F. Hanaoka,et al.  Xeroderma pigmentosum variant (XP‐V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity , 1999, The EMBO journal.

[22]  J. Mccormick,et al.  Frequency of ultraviolet light-induced mutations is higher in xeroderma pigmentosum variant cells than in normal human cells , 1976, Nature.

[23]  Hiroki Inui,et al.  Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk. , 2003, Human molecular genetics.

[24]  M. Paterson,et al.  Xeroderma pigmentosum cells with normal levels of excision repair have a defect in DNA synthesis after UV-irradiation. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Woodgate,et al.  Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations. , 2007, Cancer research.

[26]  A. Lehmann.  DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. , 2003, Biochimie.

[27]  R. Laposa,et al.  Recapitulation of the cellular xeroderma pigmentosum-variant phenotypes using short interfering RNA for DNA polymerase H. , 2003, Cancer research.

[28]  E. G. Frank,et al.  Increased Catalytic Activity and Altered Fidelity of Human DNA Polymerase ι in the Presence of Manganese* , 2007, Journal of Biological Chemistry.

[29]  J. Vos,et al.  Defective bypass replication of a leading strand cyclobutane thymine dimer in xeroderma pigmentosum variant cell extracts. , 1998, Cancer Research.

[30]  R. Woodgate.  A plethora of lesion-replicating DNA polymerases. , 1999, Genes & development.

[31]  S. TD.,et al.  Information Content of Individual Genetic Sequences , 1998 .

[32]  T. Eki,et al.  Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene , 2000, Oncogene.

[33]  J. Utikal,et al.  Molecular genetics of Xeroderma pigmentosum variant , 2003, Experimental dermatology.

[34]  T. D. Schneider,et al.  Sequence walkers: a graphical method to display how binding proteins interact with DNA or RNA sequences. , 1997, Nucleic acids research.

[35]  E. Jung,et al.  Pigmented Xerodermoid: first report of a family. , 1978, Bulletin du cancer.

[36]  T. D. Schneider,et al.  Information analysis of human splice site mutations , 1998, Human mutation.

[37]  B. Van Houten,et al.  Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. , 2003, Molecular cell.

[38]  T. Kunkel,et al.  The Y-family of DNA polymerases. , 2001, Molecular cell.

[39]  H. van Steeg,et al.  Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. , 1999, Molecular medicine today.

[40]  B. Flaxman,et al.  DNA repair in tumor cells from the variant form of xeroderma pigmentosum. , 1975, The Journal of investigative dermatology.

[41]  C. Land,et al.  Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population. , 2006, Mutation research.

[42]  A. Lehmann,et al.  Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Sikandar G. Khan,et al.  Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients. , 2002, The Journal of investigative dermatology.

[44]  E. G. Frank,et al.  Isolation and characterization of novel plasmid-encoded umuC mutants , 1994, Journal of bacteriology.

[45]  R. Tarone,et al.  A simple and rapid method for evaluating the survival of xeroderma pigmentosum lymphoid lines after irradiation with ultraviolet light , 1981, In Vitro.

[46]  R. Woodgate,et al.  Crystal Structure of a Y-Family DNA Polymerase in Action A Mechanism for Error-Prone and Lesion-Bypass Replication , 2001, Cell.

[47]  G. Wider,et al.  Ubiquitin-Binding Domains in Y-Family Polymerases Regulate Translesion Synthesis , 2005, Science.

[48]  H. Inui,et al.  Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type. , 2007, The Journal of investigative dermatology.

[49]  M. Skoneczny,et al.  Polymerase eta is a short-lived, proteasomally degraded protein that is temporarily stabilized following UV irradiation in Saccharomyces cerevisiae. , 2007, Journal of molecular biology.

[50]  F. Hanaoka,et al.  Mechanisms of accurate translesion synthesis by human DNA polymerase η , 2000, The EMBO journal.

[51]  Thomas D. Schneider,et al.  Rogan PK, Faux BM, Schneider TD. 1998. Information analysis of human splice site mutations. Hum Mutat 12:153–171. , 1999 .

[52]  S. Antonarakis,et al.  Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .

[53]  Chikahide Masutani,et al.  The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η , 1999, Nature.

[54]  L. Mullenders,et al.  Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. , 2001, Genes & development.

[55]  C. Arlett,et al.  The influence of caffeine on cell survival in excision-proficient and excision-deficient xeroderma pigmentosum and normal human cell strains following ultraviolet-light irradiation. , 1975, Mutation research.

[56]  R. Kucherlapati,et al.  Participation of mouse DNA polymerase ι in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer , 2006, Proceedings of the National Academy of Sciences.

[57]  P. Lipsky,et al.  The Role of Polymerase η in Somatic Hypermutation Determined by Analysis of Mutations in a Patient with Xeroderma Pigmentosum Variant , 2002, The Journal of Immunology.

[58]  Colin Collins,et al.  DNA polymerase η undergoes alternative splicing, protects against UV sensitivity and apoptosis, and suppresses Mre11‐dependent recombination , 2001, Genes, chromosomes & cancer.

[59]  W. Lambert,et al.  The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. , 1994, Archives of dermatology.

[60]  Sikandar G. Khan,et al.  A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. , 2000, Carcinogenesis.

[61]  R. Woodgate,et al.  Localization of DNA polymerases η and ι to the replication machinery is tightly co‐ordinated in human cells , 2002, The EMBO journal.

[62]  Robert E. Johnson,et al.  Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Poleta. , 1999, Science.

[63]  M. Yamaizumi,et al.  A simple method for diagnosing xeroderma pigmentosum variant. , 1996, The Journal of investigative dermatology.

[64]  D. Mitchell,et al.  Evidence from mutation spectra that the UV hypermutability of xeroderma pigmentosum variant cells reflects abnormal, error-prone replication on a template containing photoproducts , 1993, Molecular and cellular biology.

[65]  C. W. Graham,et al.  Nucleotide Excision Repair , 2006 .

[66]  A. Lehmann,et al.  Impaired Translesion Synthesis in Xeroderma Pigmentosum Variant Extracts Xeroderma Pigmentosum Variant Extracts Impaired Translesion Synthesis In , 2022 .

[67]  J P McDonald,et al.  Is Dna Damage Inducible and Functions in a Novel Error-free Postreplication Repair Mechanism , 1997 .

[68]  I. Rapin,et al.  Cockayne syndrome and xeroderma pigmentosum , 2000, Neurology.

[69]  Robert E. Johnson,et al.  hRAD30 mutations in the variant form of xeroderma pigmentosum. , 1999, Science.

[70]  H. L. Waters,et al.  Ultraviolet hypermutability of a shuttle vector propagated in xeroderma pigmentosum variant cells. , 1993, The Journal of investigative dermatology.

[71]  K. Sugasawa,et al.  In Vivo Destabilization and Functional Defects of the Xeroderma Pigmentosum C Protein Caused by a Pathogenic Missense Mutation , 2007, Molecular and Cellular Biology.

[72]  A. Lehmann,et al.  Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. , 2000, Cancer research.

[73]  S. Linn,et al.  XP43TO, previously classified as xeroderma pigmentosum Group E, should be reclassified as xeroderma pigmentosum variant. , 2001, The Journal of investigative dermatology.

[74]  J. Mccormick,et al.  Caffeine enhancement of the cytotoxic and mutagenic effect of ultraviolet irradiation in a xeroderma pigmentosum variant strain of human cells. , 1976, Biochemical and biophysical research communications.

[75]  T. D. Schneider,et al.  The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. , 2002, Nucleic acids research.